ASCB is pleased to announce that Lovell Jones, Emeritus Professor at both the University of Texas M.D. Anderson Cancer Center and the University of Texas Graduate School of Biomedical Sciences at Houston will present the 2020 E. E. Just Awards Lecture at Cell Bio Virtual 2020–an ASCB|EMBO online meeting.
The American Society for Cell Biology is pleased to announce that Jennifer Lippincott-Schwartz will present this year’s E.B. Wilson Award Lecture at Cell Bio Virtual 2020–an Online ASCB|EMBO Meeting. The talk will be presented online on December 10, 2020, at 2:30 PM - 3:15 PM ET.
People taking dummy pills and statins experienced similar side effects in a new study.
The 2020 Women in Cell Biology Mid-Career Award of the American Society for Cell Biology is being shared by Anne Carpenter, Institute Scientist and Senior Director of the Imaging Platform, Broad Institute of MIT and Harvard; and Daniela Nicastro, a professor in the Department of Cell Biology at University of Texas Southwestern (UTSW) Medical Center.
“Inclusive Science and Institutional Change” will be the title of the Diversity Keynote presented by invited speaker Sylvia Hurtado for Cell Bio Virtual 2020–an ASCB|EMBO online meeting. Hurtado is a professor in the Graduate School of Education and Information Studies at the University of California, Los Angeles (UCLA). The Diversity Keynote will premiere on December 3 at 11:45 am ET in the Cell Bio Virtual 2020 online platform.
Study finds that in a diverse, global patient population, a minimal monitoring (MINMON) approach to hepatitis C treatment was safe and achieved comparable sustained virologic response (SVR) to current standard of care.
New research confirms large breath shields protect patients and physicians against droplets which spread COVID-19.
El 14 de noviembre, durante la Reunión Científica Anual virtual, la Dra. Luz Fonacier de Mineola NY, fue instalada como presidenta del ACAAI. La Dra. Fonacier es la cuarta mujer y la primera presidenta asiático-americana de la ACAAI.
Luz Fonacier, MD, of Mineola NY, was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the virtual ACAAI Annual Scientific Meeting on November 15.
Research using the American Academy of Ophthalmology’s IRIS Registry to be presented at AAO 2020 Virtual.
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.
A new study being presented at this year’s virtual ACAAI Annual Scientific Meeting shows that nearly one in five parents of food-allergic kids are the target of bullying by a multitude of sources.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation, outperforming the older model for end-stage liver disease (MELD) scoring. This advancement could lead to the development of more equitable organ allocation systems and even reduce liver transplant waitlist death rates for patients.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that U.S. states that took part in the Affordable Care Act’s Medicaid expansion, which extended health care coverage to more low-income citizens, improved liver transplant waitlist placement, especially for certain racial groups.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases (AASLD)– found that among pregnant women with hepatitis C virus (HCV), more than 25 percent were initially diagnosed during pregnancy screenings, which supports prenatal care as an important opportunity to screen for HCV in women. However, the study also found that less than one third of infants receive appropriate HCV testing, a significant care gap.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that in 2019, more than 500,000 persons died of hepatitis B virus infection, highlighting the urgent need for universal HBV vaccination of children beginning at birth, and scaling up testing and access to care and treatment before people with the virus develop life-threatening liver cirrhosis or liver cancer.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that while neighborhood socioeconomic deprivation is associated with worse adverse long-term outcomes after liver transplant in children, improving center-specific practices can mitigate these effects for young at-risk patients.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the distribution of a person’s body fat affects coronary heart disease risk, with an increased risk of heart events among people with a combination of high visceral adipose tissue (VAT) – abdominal fat─ and low liver fat. The study’s findings indicate that liver triglyceride regulation plays an important role in heart health in people with discordant visceral adipose tissue and liver fat levels.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the burden of cirrhosis in women in North America has increased substantially in recent years, a worrying trend driven by a rise in alcohol-related liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD). Projections suggest that both ALD and NAFLD rates will result in even higher cirrhosis incidence by 2040, with the most worrisome upward trends seen in young women with ALD and post-menopausal women with NAFLD.
ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that COVID-19 coagulation impairment, driven in part by endothelial Factor VIII, is associated with liver injury in infected patients. The study’s findings also show that IL-6 trans-signaling, which may play a role in COVID-19 development, results in prothrombotic liver sinusoidal endothelial cells (LSECs) that may mediate the liver injury via elevated Factor VIII and activation of coagulation in the liver microvasculature.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right